Weight loss medications, including compounded Semaglutide, compounded Tirzepatide, Phentermine, Phentermine +Topiramate, and Metformin, are prescribed to support lifestyle changes like diet and exercise when specific criteria are met. These medications are most effective when combined with a structured weight management program.
To be eligible, patients must:
• Be 18 years or older and not pregnant
• Have a Body Mass Index (BMI) of ≥30 kg/m² to qualify for any of the medications, or
• Have a BMI of ≥27 kg/m² with at least one weight-related risk factor (e.g., high blood pressure, type 2 diabetes, high cholesterol) to start Phentermine, Phentermine +Topiramate, Metformin, or compounded Tirzepatide, or
• Have a BMI of ≥25 kg/m² with at least one weight-related risk factor (e.g., high blood pressure, type 2 diabetes, high cholesterol) to start compounded Semaglutide. Compounded Semaglutide (active ingredient in Ozempic™️) and Tirzepatide (active ingredient in Mounjaro™️ and Zepbound™️), Phentermine, and Phentermine +Topiramate are prepared in licensed, U.S.-based compounding pharmacies that comply with FDA regulations. However, compounded medications are not FDA-approved and may differ in effectiveness, safety, and potential side effects compared to brand-name drugs. Newman Clinic partners exclusively with trusted 503(a) Compounding Pharmacies and 503(b) Outsourcing Facilities that adhere to strict quality and safety standards. These compounded medications are not affiliated with Novo Nordisk, Eli Lilly and Company, or any other brand or pharmaceutical company. If you prefer an FDA-approved medication, please consult your personal healthcare provider.
GLP-1 side effects and contraindications are reviewed in The Newman Script, “Compounded Semaglutide Dosage Chart: Your Guide to Safe Weight Loss”.
Phentermine may cause common side effects, such as dry mouth, constipation, difficulty sleeping, dizziness, and mood or cognitive changes. Topiramate may cause tingling sensations, taste changes, memory issues, and an increased risk of kidney stones. Not recommended for individuals with heart disease, uncontrolled high blood pressure, seizure disorder, hyperthyroidism, glaucoma, or those taking SSRIs or MAOIs. Serious risks include birth defects during pregnancy. Phentermine is contraindicated for individuals with a history of illicit drug use or substance abuse. Regular blood pressure monitoring is recommended when using phentermine, and routine electrolyte and creatinine tests, along with monthly pregnancy tests or contraception, are advised when using phentermine with topiramate.
All medications will be reviewed for specific contraindications during the intake process.
